Possible mechanisms of retinal function recovery with the use of cell therapy with bone marrow-derived stem cells;Possíveis mecanismos de recuperação da função da retina com uso de terapia celular com células tronco derivadas da medula óssea

Arquivos Brasileiros de Oftalmologia

Volumn 73, Issue 5, 2010, Pages 474-479

  Siqueira, Rubens Camargo ^a,b   Voltarelli, Júlio Cesar ^a   Messias, André Marcio Vieira ^a   Jorge, Rodrigo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade de Medicina de Catanduva   (Brazil)

Author keywords

Bone marrow; Retinal degeneration; Retinitis pigmentosa; Stem cell

Indexed keywords

ANIMAL; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONVALESCENCE; CYTOLOGY; HUMAN; MOUSE; PARACRINE SIGNALING; PIGMENT EPITHELIUM; RETINA DEGENERATION; STEM CELL TRANSPLANTATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; HUMANS; MICE; MODELS, ANIMAL; PARACRINE COMMUNICATION; RECOVERY OF FUNCTION; RETINAL DEGENERATION; RETINAL PIGMENT EPITHELIUM; STEM CELL TRANSPLANTATION;

EID: 78651513390     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492010000500019     Document Type: Article

References (55)

1. Lorenz E, Congdon C, Uphoff ED, R. Modification of acute irradiation injury in mice and guinea-pigs by bone marrow injections. Radiology. 1951;58:863-77.
2. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961;14:213-22.
3. Lanza R, Rosenthal N. The stem cell challenge. Sci Am. 2004;290:93-9.
4. Mimeault M, Batra SK. Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells. 2006;24(11):2319-45.
5. Ortiz-Gonzalez XR, Keene CD, Verfaillie C, Low WC. Neural induction of adult bone marrow and umbilical cord stem cells. Curr Neurovasc Res. 2004;1(3):207-13.
6. Trounson A. The production and directed differentiation of human embryonic stem cells. Endocr Rev. 2006;27(2):208-19. Review.
7. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2002;97(21):11307-12.
8. Machaliñska A, Baumert B, Kuprjanowicz L, Wiszniewska B, Karczewicz D, Machaliñski A, Baumert B, Kuprjanowicz L, Wiszniewska B, Karczewicz D, Machaliñski B. Potential application of adult stem cells in retinal repair-challenge for regenerative medicine. Curr Eye Res. 2009;34(9):748-60.
9. Enzmann V, Yolcu E, Kaplan HJ, Ildstad ST. Stem cells as tools in regenerative therapy for retinal degeneration. Arch Ophthalmol. 2009;127(4):563-71.
10. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia. 2004;18(1):29-40.
11. Müller-Sieburg CE, Cho RH, Thoman M, Adkins B, Sieburg HB. Deterministic regulation of hematopoietic stem cell self-renewal and differentiation. Blood. 2002; 100(4):1302-9.
12. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241(4861):58-62. Erratum in: Science. 1989; 244(4908):1030.
13. Nielsen JS, McNagny KM. CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation. 2009;16(6):487-96.
14. Kuçi S, Kuçi Z, Latifi-Pupovci H, Niethammer D, Handgretinger R, Schumm M, et al. Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine. Curr Stem Cell Res Ther. 2009;4(2):107-17.
15. Challen GA, Boles N, Lin KK, Goodell MA. Mouse hematopoietic stem cell identification and analysis. Cytometry A. 2009;75(1):14-24. Review.
16. Voltarelli JC, Ouyang J. Hematopoietic stem cell transplantation for autoimmune diseases in developing countries: current status and future prospectives. Bone Marrow Transplant. 2003;32 Suppl 1:S69-71.
17. Voltarelli JC. Applications of flow cytometry to hematopoietic stem cell transplantation. Mem Inst Oswaldo Cruz. 2000;95(3):403-14.
18. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A; International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-5.
19. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007;25(11):2896-902.
20. Otani A, Dorrell MI, Kinder K, Moreno SK, Nusinowitz S, Banin E, et al. Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J Clin Invest. 2004;114(6):765-74. Comment in: J Clin Invest. 2004;114(6):755-7.
21. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, Friedlander M. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med. 2002;8(9):1004-10. Comment in: Nat Med. 2002;8(9): 932-4.
22. Sasahara M, Otani A, Oishi A, Kojima H, Yodoi Y, Kameda T, et al. Activation of bone marrow-derived microglia promotes photoreceptor survival in inherited retinal degeneration. Am J Pathol. 2008;172(6):1693-703.
23. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81(6): 1345-51.
24. Schuetz E, Thanos S. Microglia-targeted pharmacotherapy in retinal neurodege-nerative diseases. Curr Drug Targets. 2004;5(7):619-27.
25. Crisostomo PR, Markel TA, Wang Y, Meldrum DR. Surgically relevant aspects of stem cell paracrine effects. Surgery. 2008;143(5):577-81.
26. Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol. 2005;39(2):363-76.
27. Oh JY, Kim MK, Shin MS, Lee HJ, Ko JH, Wee WR, Lee JH. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells. 2008;26(4):1047-55.
28. Gomei Y, Nakamura Y, Yoshihara H, Hosokawa K, Iwasaki H, Suda T, Arai F. Functional differences between two Tie2 ligands, angiopoietin-1 and -2, in the regulation of adult bone marrow hematopoietic stem cells. Exp Hematol. 2010; 38(2):82-9.
29. Li N, Li XR, Yuan JQ. Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion. Graefes Arch Clin Exp Ophthalmol. 2009;247(4):503-14.
30. Markel TA, Wang Y, Herrmann JL, Crisostomo PR, Wang M, Novotny NM, et al. VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol. 2008;295(6):H2308-14.
31. Markel TA, Crisostomo PR, Wang M, Herring CM, Meldrum DR. Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Am J Physiol Gastrointest Liver Physiol. 2007;293(4): G657-62.
32. Saini V, Shoemaker RH. Potential for therapeutic targeting of tumor stem cells. Cancer Sci. 2010;101(1):16-21.
33. Zhang P, Li J, Liu Y, Chen X, Kang Q, Zhao J, Li W. Human neural stem cell transplantation attenuates apoptosis and improves neurological functions after cerebral ischemia in rats. Acta Anaesthesiol Scand. 2009;53(9):1184-91.
34. Wang M, Tsai BM, Crisostomo PR, Meldrum DR. Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock. 2006;25(5):454-9.
35. Koontongkaew S, Amornphimoltham P, Yapong B. Tumor-stroma interactions influence cytokine expression and matrix metalloproteinase activities in paired primary and metastatic head and neck cancer cells. Cell Biol Int. 2009;33(2):165-73.
36. Wu Y, Wang J, Scott PG, Tredget EE. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007;15 Suppl 1:S18-26. Erratum in: Wound Repair Regen. 2008;16(4):582.
37. Cheng AS, Yau TM. Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies. Semin Thorac Cardiovasc Surg. 2008;20(2):94-101.
38. Harris JR, Brown GA, Jorgensen M, Kaushal S, Ellis EA, Grant MB, Scott EW. Bone marrow-derived cells home to and regenerate retinal pigment epithelium after injury. Invest Ophthalmol Vis Sci. 2006;47(5):2108-13.
39. Binder S, Stanzel BV, Krebs I, Glittenberg C. Transplantation of the RPE in AMD. Prog Retin Eye Res. 2007 Sep;26(5):516-54. Epub 2007 Mar 6. Review
40. Harris JR, Fisher R, Jorgensen M, Kaushal S, Scott EW. CD133 progenitor cells from the bone marrow contribute to retinal pigment epithelium repair. Stem Cells. 2009;27(2):457-66.
41. Wang S, Lu B, Girman S, Duan J, McFarland T, Zhang QS, et al. Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. PLoS One. 2010;5(2):e9200.
42. Zhang Y, Wang W. Effects of bone marrow mesenchymal stem cell transplantation on light-damaged retina. Invest Ophthalmol Vis Sci. 2010;51(7):3742-8.
43. Uteza Y, Rouillot JS, Kobetz A, Marchant D, Pecqueur S, Arnaud E, et al. Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats. Proc Natl Acad Sci U S A. 1999;96(6):3126-31.
44. Tomita M, Adachi Y, Yamada H, Takahashi K, Kiuchi K, Oyaizu H, et al. Bone marrow-derived stem cells can differentiate into retinal cells in injured rat retina. Stem Cells. 2002;20(4):279-83.
45. Meyer JS, Katz ML, Maruniak JA, Kirk MD. Embryonic stem cell-derived neural progenitors incorporate into degenerating retina and enhance survival of host photoreceptors. Stem Cells. 2006;24(2):274-83.
46. Siqueira RC, Abad L, Benson G, Sami M. Behaviour of stem cells in eyes of rabbits with chorioretinal injuries caused by laser red diode 670N-M. In: Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), 2008, Fort Lauderdale. Invest Ophthalmol Vis Sci. 2008;49:536.
47. Siqueira RC. Terapia celular nas doenças oftalmológicas. Rev Bras Hematol Hemoter. 2009;31(Supl 1):120-7.
48. Wang HC, Brown J, Alayon H, Stuck BE. Transplantation of quantum dot-labelled bone marrow-derived stem cells into the vitreous of mice with laser-induced retinal injury: survival, integration and differentiation. Vision Res. 2010;50(7):665-73.
49. Johnson TV, Bull ND, Hunt DP, Marina N, Tomarev SI, Martin KR. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci. 2010;51(4):2051-9.
50. Castanheira P, Torquetti L, Nehemy MB, Goes AM. Retinal incorporation and differentiation of mesenchymal stem cells intravitreally injected in the injured retina of rats. Arq Bras Oftalmol. 2008;71(5):644-50.
51. Jonas JB, Witzens-Harig M, Arseniev L, Ho AD. Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report. Acta Ophthalmol. 2008;86(2):225-6.
52. Jonas JB, Witzens-Harig M, Arseniev L, Ho AD. Intravitreal autologous bone-marrow-derived mononuclear cell transplantation. Acta Ophthalmol. 2010; 88(4):e131-2.
53. Siqueira RC, Messias A, Voltarelli JC, Scott I, Jorge R. Autologous bone marrow derived stem cells transplantation for retinitis pigmentosa. Cytotherapy. 2010;12 Suppl 1:58.
54. ClinicalTrials.gov.[Internet]. Autologous Bone Marrow-Derived Stem Cells Transplantation for Retinitis Pigmentosa. NCT01068561.[cited 2010 July 30]. Available at:
55. Siqueira RC. Transplante autólogo do epitélio pigmentado da retina na degeneração macular relacionada com a idade. Arq Bras Oftalmol. 2009;72(1):123-30.